戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ples were selected from the Penn FTD Center (University of Pennsylvania).
2 enerative Disease Research Brain Bank at the University of Pennsylvania.
3 genetics at the Perelman School of Medicine, University of Pennsylvania.
4 s relevance to recent human evolution at the University of Pennsylvania.
5  scans were performed at the Hospital of the University of Pennsylvania.
6 ted schools or hospitals affiliated with the University of Pennsylvania.
7 prehensive cancer center affiliated with the University of Pennsylvania.
8 MA), we analyzed 449 patients treated at the University of Pennsylvania.
9 s career as a Professor of Psychology at the University of Pennsylvania.
10 ital of Philadelphia and the Hospital of the University of Pennsylvania.
11 gen receptor T-cell therapy developed at the University of Pennsylvania.
12 or antibodies to DNER at the hospital of the University of Pennsylvania.
13 Diseases and Center for AIDS Research of the University of Pennsylvania.
14 thologists blinded to the prior diagnoses at University of Pennsylvania.
15 d Davis Institute of Health Economics at the University of Pennsylvania.
16 ess Unrestricted Grant; Parker Family Chair; University of Pennsylvania.
17  human samples from the ITMAT Biobank at the University of Pennsylvania.
18 ice and Oncology Unit of the Hospital of the University of Pennsylvania (2009-2010).
19 spital (12 patients) and the Hospital of the University of Pennsylvania (34 patients).
20 ar disease (CVD) in women by following 1,564 University of Pennsylvania alumnae (mean age, 45.5 years
21 t study was conducted at the Hospital of the University of Pennsylvania among 2038 consecutive patien
22 , and April 31, 2013, at the Hospital of the University of Pennsylvania, an academic medical center.
23 anuary 7, 2015, and February 2, 2018, at the University of Pennsylvania and 51 148 DM/DBT examination
24  postpartum individuals who delivered at the University of Pennsylvania and had a hypertensive disord
25 viduals seen over a 5-year period within the University of Pennsylvania and the Mass General Brigham
26 noma were collected from the Hospital of the University of Pennsylvania and the radiologic archives o
27       Antibody studies were performed at the University of Pennsylvania and the University of Barcelo
28 logists' diagnoses from two research centres-University of Pennsylvania and University of Kentucky.
29  SOTRs with an EB BSI at the Hospital of the University of Pennsylvania and University of Maryland Me
30 on: 4.4% (Baylor), 8.0% (Georgetown), 32.6% (University of Pennsylvania), and 45.0% (Mount Sinai).
31 st Chair of the Department of Surgery at the University of Pennsylvania, and Dorsey's uncle), the new
32 rs: University of California, San Francisco, University of Pennsylvania, and Duke University.
33 l Center; Perelman School of Medicine at the University of Pennsylvania; and European Atherosclerosis
34 n college athletes at Harvard University and University of Pennsylvania, as well as the follow-up of
35 irst-time AF ablation at the Hospital of the University of Pennsylvania between 2018 and 2022 were id
36 standard provocation, at the Hospital of the University of Pennsylvania between 2022 and 2024.
37  consecutive adult alloHCT recipients at the University of Pennsylvania between April 2015 and Novemb
38 ents who received a diagnosis of MpBC at the University of Pennsylvania between January 2010 and May
39 utive series of WOP and IIT performed at the University of Pennsylvania between September 2001 and Fe
40 orted by the Cardiovascular Institute of the University of Pennsylvania, by the MedStar Health Resear
41                          Sections from these University of Pennsylvania cases were cut from amygdala,
42 titute of Allergies and Infectious Diseases; University of Pennsylvania Center for AIDS Research.
43 st to the institutional review boards at the University of Pennsylvania, Children's Hospital of Phila
44            All of the endophenotypes and the University of Pennsylvania Computerized Neurocognitive B
45 ber Sequencing test, and 6 measures from the University of Pennsylvania Computerized Neurocognitive B
46                Hammond as professor, and the University of Pennsylvania created a clinical professors
47               The study was conducted at the University of Pennsylvania Cutaneous Lymphoma Clinic and
48 ouble-blind clinical trial, conducted at the University of Pennsylvania Division of Plastic Surgery c
49  at 4 medical centers: Mass General Brigham, University of Pennsylvania, Emory University, and Fenway
50 apy for recurrent or metastatic HNSCC at the University of Pennsylvania from January 1, 2015, through
51 ts who underwent ERCP at the Hospital of the University of Pennsylvania, from 2009 and 2015, includin
52               Sigma Theta Tau International, University of Pennsylvania Global Engagement Fund, Unive
53                                  The NIH and University of Pennsylvania groups reported the detection
54 ed from July 2017 through August 2018 at the University of Pennsylvania Health System (UPHS), an urba
55 es study was conducted among patients at the University of Pennsylvania Health System and in partners
56                                              University of Pennsylvania Health System and the Palliat
57 ient and outpatient notes written within the University of Pennsylvania Health System from January 1,
58                                          The University of Pennsylvania Health System in Philadelphia
59  January 1, 2005 to June 1, 2013, within the University of Pennsylvania Health System were identified
60 ine BioBank (PMBB) enrolling patients of the University of Pennsylvania Health System's clinical prac
61 ents at a large academic health care system (University of Pennsylvania Health System) and a private
62  through December 31, 2016, performed at the University of Pennsylvania Health System, a tertiary ref
63 inistered by the Center for Bioethics at the University of Pennsylvania Health System, extensively re
64 rom October 4, 2018, to May 27, 2021, at the University of Pennsylvania Health System, Philadelphia.
65 ring an Omicron surge among employees of the University of Pennsylvania Health System.
66  intensive care unit (ICU) admissions at the University of Pennsylvania Health System.
67 e recruited from oncology clinics within the University of Pennsylvania Health System.
68 d fifty-one probands ascertained through the University of Pennsylvania high-risk clinic, all with co
69  in 2 tertiary care academic cancer centers (University of Pennsylvania Hospital Abramson Cancer Cent
70 med for 80 patients from the Hospital of the University of Pennsylvania (HUP) listed from July 1986 t
71  postgraduate course in ophthalmology at the University of Pennsylvania in 1923.
72 ents were recruited from the hospital of the University of Pennsylvania in Philadelphia, PA, USA.
73 onducted across wards of the Hospital of the University of Pennsylvania) included all persons eligibl
74 lected on 302 transplant recipients from the University of Pennsylvania, including 53 patients with e
75 udy included data from 2009 to 2020 from the University of Pennsylvania Integrated Neurodegenerative
76 eld professorships at McGill University, the University of Pennsylvania, Johns Hopkins University, an
77 37915, DK097307, HL115354, HL101779, and the University of Pennsylvania McCabe Fund Fellowship Award.
78                              In 1991, 80% of University of Pennsylvania medical students felt that nu
79 American; 41% female) were selected from the University of Pennsylvania Medicine BioBank with plasma
80  recipients from Columbia University and the University of Pennsylvania (N = 738).
81 dings in an independent ADHF cohort from the University of Pennsylvania (n = 876).
82                                              University of Pennsylvania-Novartis Alliance and NIH.
83 Microbiology Testing Laboratory (MTL) of the University of Pennsylvania over a 2-year period.
84 Predictors of outcome were determined at the Universities of Pennsylvania (PA, USA) and Barcelona (Sp
85 2 cohorts: (1) consecutive admissions at the University of Pennsylvania (Penn) with a primary dischar
86  at the Children's Hospital of Philadelphia, University of Pennsylvania (Penn), and via a Penn Dermat
87 he Matthew J Ryan Veterinary Hospital of the University of Pennsylvania (PennVet).
88                                              University of Pennsylvania Perelman School of Medicine.
89 nia, Berkeley), Donald Ringe and Ann Taylor (University of Pennsylvania, Philadelphia), and me, for a
90 ion therapy (n = 218) at the Hospital of the University of Pennsylvania, Philadelphia, or RT (n = 766
91 Mesothelioma Conference that was held at the University of Pennsylvania, Philadelphia, PA, May 13-16,
92 : New York Brain Bank, New York, USA (NYBB); University of Pennsylvania, Philadelphia, PA, USA (UPENN
93 erous German-speaking scholars coming to the University of Pennsylvania, Philadelphia, with Albert Kl
94 exas; Cleveland Clinic, Cleveland, Ohio; and University of Pennsylvania, Philadelphia.
95 STIM1 promoter using the TESS search system (University of Pennsylvania) revealed four putative respo
96 aged 18 to 73 years and were enrolled in the University of Pennsylvania's Cutaneous Lupus Erythematos
97 8 to 2001; n = 26,291) and those seen by the University of Pennsylvania's Pigmented Lesion Group (PLG
98                               Not so for the University of Pennsylvania's School of Medicine commence
99                                          The University of Pennsylvania School of Medicine has develo
100 school faculty with disabilities, drawing on University of Pennsylvania School of Medicine initiative
101 tion Education and Prevention Program at the University of Pennsylvania School of Medicine is a succe
102 s Hopkins University School of Medicine, the University of Pennsylvania School of Medicine, the Unive
103 administration and core faculty group at the University of Pennsylvania School of Medicine.
104 sity of Pennsylvania Global Engagement Fund, University of Pennsylvania School of Nursing's Center fo
105  Coding (g = -0.67; 95% CI, -0.95 to -0.39), University of Pennsylvania Smell Identification Test (g
106 age- and sex-standardized performance on the University of Pennsylvania Smell Identification Test (UP
107 s old with current olfactory loss defined as University of Pennsylvania Smell Identification Test (UP
108      Participants were invited to complete a University of Pennsylvania Smell Identification Test (UP
109 on-Severity (CGI-S) smell questionnaire, the University of Pennsylvania Smell Identification Test (UP
110 ary outcome measures included changes in the University of Pennsylvania Smell Identification Test (UP
111 less Empirical Taste Test (WETT) and 40-item University of Pennsylvania Smell Identification Test (UP
112 SARS), Montreal Cognitive assessment (MoCA), University of Pennsylvania Smell Identification Test (UP
113  >/=8.90), sense of smell assessed using the University of Pennsylvania Smell Identification Test (UP
114 Participants were evaluated with the 40-item University of Pennsylvania Smell Identification Test (UP
115                    All were administered the University of Pennsylvania Smell Identification Test (UP
116       All participants were administered the University of Pennsylvania Smell Identification Test (UP
117    Baseline olfaction was measured using the University of Pennsylvania Smell Identification Test (UP
118 isual analog scale [VAS] and psychophysical, University of Pennsylvania Smell Identification Test [UP
119 tilt positions using two different measures: University of Pennsylvania Smell Identification Test and
120                                              University of Pennsylvania Smell Identification Test dat
121  10-item scale performed comparably with the University of Pennsylvania Smell Identification Test in
122                               SNOT-22 score, University of Pennsylvania Smell Identification Test sco
123  score, Sinonasal Outcome Test 22 score, and University of Pennsylvania Smell Identification Test sco
124 nts and 100 lowest-risk participants, median University of Pennsylvania Smell Identification Test sco
125                                          The University of Pennsylvania Smell Identification Test was
126                                          The University of Pennsylvania Smell Identification Test was
127  Sino-Nasal Outcome Test-22 (SNOT-22) score, University of Pennsylvania Smell Identification Test, se
128 , and at 2 years, significant differences in University of Pennsylvania Smell Identification Test, Un
129 le factors), a keyboard-tapping task and the University of Pennsylvania Smell Identification Test.
130 ification was also assessed using a modified University of Pennsylvania Smell Identification Test.
131 on tomography and olfactory testing with the University of Pennsylvania Smell Identification Test.
132 40 normal subjects was compared by using the University of Pennsylvania Smell Identification Test.
133 y controls, in four olfactory tasks: (i) the University of Pennsylvania smell identification test; (i
134      In multivariate analyses, baseline age, University of Pennsylvania Smell Inventory Test (UPSIT)
135                           Dr Ruth J Muschel (University of Pennsylvania) spoke about work, conducted
136 w of students tested for tuberculosis at the University of Pennsylvania Student Health Service betwee
137 was completed in 1813 by John Syng Dorsey, a University of Pennsylvania surgeon.
138 to a previous brain scanner developed at the University of Pennsylvania, the HEAD Penn-PET, but the d
139 blinded crossover trial was conducted at the University of Pennsylvania, the Philadelphia Veterans Af
140 nally followed Discovery Cohort based at the University of Pennsylvania (UPenn), we measured levels o
141 normal control subjects (NC; n = 137) at the University of Pennsylvania (UPenn).
142 ortium and the Abramson Cancer Center of the University of Pennsylvania was convened on December 1, 2
143 red by The National Cancer Institute and the University of Pennsylvania, was held from December 1 to
144  Hospital, Johns Hopkins University, and the University of Pennsylvania were included.
145 radiation from June 1992 to June 1998 at the University of Pennsylvania were reviewed.
146 ts seen in the Dermatology Department of the University of Pennsylvania, who were diagnosed with nonm
147 er patients treated from 1977 to 1995 at the University of Pennsylvania with conventional tangential
148 lant recipients between 2002 and 2006 at the University of Pennsylvania with follow-up through 2010.
149          First, cases were selected from the University of Pennsylvania with pathological diagnoses o

 
Page Top